PROPEA

PROPEA STEPCARE is a continuation of the PROPEA3 study that suggested that the restitution of electroencephalogram (EEG) slow wave activity (SWA), particularly in the early phase, may have prognostic potential in predicting favourable functional outcome after OHCA. 

Documents
19 Mar 2024 ‐ Neurological prognostication